天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Welcome to chemicalbook!
+1 (818) 612-2111
Inquriy
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >API>Circulatory system drugs>Lipid regulating drugs>Hesperidin
Hesperidin
  • Hesperidin
  • Hesperidin
  • Hesperidin
  • Hesperidin
  • Hesperidin

Hesperidin NEW

Price Get Latest Price
Package 1KG 100KG 1000KG
Min. Order: 1KG
Supply Ability: 50000kg/Month
Update Time: 2024-04-12

Product Details

Product Name: Hesperidin CAS No.: 520-26-3
EC-No.: 208-288-1 Min. Order: 1KG
Purity: 98% Supply Ability: 50000kg/Month
Release date: 2024/04/12
Appearance : Yellow-brown powder MF: C28H34O15

Product Description:

  Hesperidin is a disaccharide derivative that consists of hesperetin substituted by a 6-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranosyl moiety at position 7 via a glycosidic linkage. It has a role as a mutagen. It is a disaccharide derivative, a member of 3'-hydroxyflavanones, a dihydroxyflavanone, a monomethoxyflavanone, a flavanone glycoside, a member of 4'-methoxyflavanones and a rutinoside. It derives from a hesperetin.


Application:

  After hydrogenation, hesperidin is a natural sweetener, dihydrochalcone, which is 1000 times sweeter than sucrose and can be used as a functional food.

Effect:
(1) Hesperidin is a drug for the treatment of hypertension and myocardial infarction. It is used as a raw material for pharmacy in the pharmaceutical industry and is one of the main components of the Chinese patent medicine Maitong.
(2) Hesperidin has anti-lipid oxidation, scavenging oxygen free radicals, anti-inflammatory, anti-virus and anti-bacterial effects. Long-term use can delay aging and anti-cancer.


Storage   Condition

Keep in a cool   and dry place

Transportation

By Sea or   by Air(DHL/UPS/TNT/FEDEX/EMS)

Delivery Time

7-28 days

Payment

T/T,   Western Union or Bitcoin

Article illustration

Article illustration

Article illustration

Article illustration

Article illustration

Article illustration

Article illustration

Article illustration

Article illustration

Article illustration


Company Profile Introduction

Xi'an Haibo Biotechnology Co.,Ltd. is specialized in the study, production and sale of natural plant extract products,which are used in pharmaceuticaldietary supplement, food and cosmetic industries. Our company is located in Xian National High-tech Industrial Development Zone. Xian Haibo Biotech Co.,Ltd. has a number of departments including R&D, production, quality inspection, and market. The company's R&D center has a technical team specializing in research and developmentas well as advanced detection systems such as high-performance liquid chromatography, gas chromatography,and magnetic drive autoclave, experimental, pilot plant,and a number of scientific research institutions have established a good technical support relationship,with strong technical force. The company's production workshop has several plant extraction production lines, as well as advanced production equipment such as dynamic countercurrent extraction,column separatio

You may like

Recommended supplier

Product name Price   Suppliers Update time
$50.00/20mg
VIP1Y
TargetMol Chemicals Inc.
2024-11-19
$50.00/20mg
VIP5Y
TargetMol Chemicals Inc.
2024-11-19
$100.00/25KG
VIP6Y
Hebei Weibang Biotechnology Co., Ltd
2024-10-31
$9.00/1KG
VIP4Y
Hebei Chuanghai Biotechnology Co,.LTD
2024-08-20
$3.50/1kg
VIP1Y
Hebei Andu Technology Com.,Ltd
2024-08-18
$100.00/1kg
VIP1Y
HEBEI SHENGSUAN CHEMICAL INDUSTRY CO.,LTD
2024-08-16
$0.00/1kg
VIP2Y
Chongqing Zhihe Biopharmaceutical Co., Ltd.
2024-05-21
$0.00/1kg
VIP2Y
Hebei Kingfiner Technology Development Co.Ltd
2024-05-15
$18.00/10kg
VIP1Y
Hebei Shengyang Water Conservancy Engineering Co., Ltd.
2024-05-10
$15.00/1kg
Ouhuang Engineering Materials (Hubei) Co., Ltd
2024-04-28
  • Since: 2020-08-05
  • Address: 804, Unit 2, Building 4, i City, No. 11, South Tangyan Road, High-tech Zone, Xi 'an, Shaanxi
INQUIRY